| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | RNA-directed DNA polymerase activity | 1.40e-06 | 14 | 125 | 4 | GO:0003964 | |
| GeneOntologyMolecularFunction | aspartic-type endopeptidase activity | 3.29e-06 | 37 | 125 | 5 | GO:0004190 | |
| GeneOntologyMolecularFunction | aspartic-type peptidase activity | 3.77e-06 | 38 | 125 | 5 | GO:0070001 | |
| GeneOntologyMolecularFunction | RNA-DNA hybrid ribonuclease activity | 3.81e-05 | 11 | 125 | 3 | GO:0004523 | |
| GeneOntologyMolecularFunction | high-affinity IgG receptor activity | 3.89e-05 | 2 | 125 | 2 | GO:0019771 | |
| GeneOntologyMolecularFunction | leukotriene receptor binding | 3.89e-05 | 2 | 125 | 2 | GO:0031774 | |
| GeneOntologyMolecularFunction | glucuronosyltransferase activity | 6.59e-05 | 35 | 125 | 4 | GO:0015020 | |
| GeneOntologyMolecularFunction | DNA polymerase activity | 9.16e-05 | 38 | 125 | 4 | GO:0034061 | |
| GeneOntologyMolecularFunction | methylated histone binding | 2.06e-04 | 86 | 125 | 5 | GO:0035064 | |
| GeneOntologyMolecularFunction | methylation-dependent protein binding | 2.29e-04 | 88 | 125 | 5 | GO:0140034 | |
| GeneOntologyMolecularFunction | pancreatic polypeptide receptor activity | 2.31e-04 | 4 | 125 | 2 | GO:0001602 | |
| GeneOntologyMolecularFunction | peptidase activity | LVRN ERVK-6 TMPRSS9 CPA1 ERVK-7 ADAMTS12 CAPN8 ERVK-8 ERVK-19 LTA4H ECEL1 ERVK-25 TMPRSS7 | 2.35e-04 | 654 | 125 | 13 | GO:0008233 |
| GeneOntologyMolecularFunction | RNA stem-loop binding | 2.93e-04 | 21 | 125 | 3 | GO:0035613 | |
| GeneOntologyMolecularFunction | endopeptidase activity | ERVK-6 TMPRSS9 ERVK-7 ADAMTS12 CAPN8 ERVK-8 ERVK-19 ECEL1 ERVK-25 TMPRSS7 | 3.79e-04 | 430 | 125 | 10 | GO:0004175 |
| GeneOntologyMolecularFunction | DNA/RNA hybrid binding | 3.84e-04 | 5 | 125 | 2 | GO:0071667 | |
| GeneOntologyMolecularFunction | nucleotidyltransferase activity | 3.93e-04 | 152 | 125 | 6 | GO:0016779 | |
| GeneOntologyMolecularFunction | structural molecule activity | ERVK-6 HSPG2 MXRA5 MRPL30 LMNTD2 ERVK-7 ERBIN HMCN2 IGFBP7 EHHADH ERVK-8 ERVK-19 ERVK-25 MYBPC1 MYBPC3 | 4.58e-04 | 891 | 125 | 15 | GO:0005198 |
| GeneOntologyMolecularFunction | retinoic acid binding | 7.00e-04 | 28 | 125 | 3 | GO:0001972 | |
| GeneOntologyMolecularFunction | IgG receptor activity | 8.00e-04 | 7 | 125 | 2 | GO:0019770 | |
| GeneOntologyMolecularFunction | immunoglobulin binding | 1.47e-03 | 36 | 125 | 3 | GO:0019865 | |
| GeneOntologyMolecularFunction | RNA endonuclease activity, producing 5'-phosphomonoesters | 1.59e-03 | 37 | 125 | 3 | GO:0016891 | |
| GeneOntologyMolecularFunction | endonuclease activity | 1.66e-03 | 136 | 125 | 5 | GO:0004519 | |
| GeneOntologyMolecularFunction | myosin binding | 2.00e-03 | 85 | 125 | 4 | GO:0017022 | |
| GeneOntologyMolecularFunction | IgG binding | 2.06e-03 | 11 | 125 | 2 | GO:0019864 | |
| GeneOntologyMolecularFunction | neuropeptide Y receptor activity | 2.06e-03 | 11 | 125 | 2 | GO:0004983 | |
| GeneOntologyMolecularFunction | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters | 2.99e-03 | 46 | 125 | 3 | GO:0016893 | |
| GeneOntologyMolecularFunction | nuclease activity | 3.36e-03 | 231 | 125 | 6 | GO:0004518 | |
| GeneOntologyMolecularFunction | immunoglobulin receptor activity | 3.37e-03 | 14 | 125 | 2 | GO:0019763 | |
| GeneOntologyMolecularFunction | titin binding | 3.37e-03 | 14 | 125 | 2 | GO:0031432 | |
| GeneOntologyMolecularFunction | retinoid binding | 3.37e-03 | 48 | 125 | 3 | GO:0005501 | |
| GeneOntologyMolecularFunction | isoprenoid binding | 3.58e-03 | 49 | 125 | 3 | GO:0019840 | |
| GeneOntologyMolecularFunction | glucosidase activity | 3.87e-03 | 15 | 125 | 2 | GO:0015926 | |
| GeneOntologyMolecularFunction | carboxylic acid binding | 3.97e-03 | 239 | 125 | 6 | GO:0031406 | |
| GeneOntologyBiologicalProcess | cellular glucuronidation | 7.10e-06 | 21 | 125 | 4 | GO:0052695 | |
| GeneOntologyBiologicalProcess | glucuronate metabolic process | 1.73e-05 | 26 | 125 | 4 | GO:0019585 | |
| GeneOntologyBiologicalProcess | uronic acid metabolic process | 1.73e-05 | 26 | 125 | 4 | GO:0006063 | |
| GeneOntologyBiologicalProcess | DNA integration | 5.94e-05 | 13 | 125 | 3 | GO:0015074 | |
| Domain | LRRC37AB_C | 1.91e-09 | 4 | 125 | 4 | IPR029423 | |
| Domain | LRRC37AB_C | 1.91e-09 | 4 | 125 | 4 | PF14914 | |
| Domain | LRRC37_N | 1.91e-09 | 4 | 125 | 4 | IPR032754 | |
| Domain | LRRC37 | 1.91e-09 | 4 | 125 | 4 | PF15779 | |
| Domain | LRRC37A/B-like | 1.91e-09 | 4 | 125 | 4 | IPR015753 | |
| Domain | SPIN/Ssty | 9.51e-09 | 5 | 125 | 4 | IPR003671 | |
| Domain | Spin-Ssty | 9.51e-09 | 5 | 125 | 4 | PF02513 | |
| Domain | IG_LIKE | IL11RA HSPG2 MXRA5 HLA-DRA SIGLEC14 LRRN3 HMCN2 FCGR1A IGFBP7 FCGR1BP CNTN3 IGSF9B CD200R1L FCAMR MYBPC1 MYBPC3 | 1.83e-07 | 491 | 125 | 16 | PS50835 |
| Domain | Ig-like_dom | IL11RA HSPG2 MXRA5 HLA-DRA SIGLEC14 LRRN3 HMCN2 FCGR1A IGFBP7 FCGR1BP CNTN3 IGSF9B CD200R1L FCAMR MYBPC1 MYBPC3 | 2.53e-07 | 503 | 125 | 16 | IPR007110 |
| Domain | IGc2 | HSPG2 MXRA5 SIGLEC14 LRRN3 HMCN2 FCGR1A FCGR1BP CNTN3 IGSF9B MYBPC1 MYBPC3 | 5.21e-07 | 235 | 125 | 11 | SM00408 |
| Domain | Ig_sub2 | HSPG2 MXRA5 SIGLEC14 LRRN3 HMCN2 FCGR1A FCGR1BP CNTN3 IGSF9B MYBPC1 MYBPC3 | 5.21e-07 | 235 | 125 | 11 | IPR003598 |
| Domain | Ig_I-set | HSPG2 MXRA5 SIGLEC14 LRRN3 HMCN2 IGFBP7 CNTN3 IGSF9B MYBPC1 MYBPC3 | 6.04e-07 | 190 | 125 | 10 | IPR013098 |
| Domain | I-set | HSPG2 MXRA5 SIGLEC14 LRRN3 HMCN2 IGFBP7 CNTN3 IGSF9B MYBPC1 MYBPC3 | 6.04e-07 | 190 | 125 | 10 | PF07679 |
| Domain | IG | IL11RA HSPG2 MXRA5 SIGLEC14 LRRN3 HMCN2 FCGR1A IGFBP7 FCGR1BP CNTN3 IGSF9B FCAMR MYBPC1 MYBPC3 | 8.88e-07 | 421 | 125 | 14 | SM00409 |
| Domain | Ig_sub | IL11RA HSPG2 MXRA5 SIGLEC14 LRRN3 HMCN2 FCGR1A IGFBP7 FCGR1BP CNTN3 IGSF9B FCAMR MYBPC1 MYBPC3 | 8.88e-07 | 421 | 125 | 14 | IPR003599 |
| Domain | Ig-like_fold | IL11RA HSPG2 MXRA5 HLA-DRA INSRR SIGLEC14 LRRN3 HMCN2 FCGR1A IGFBP7 FCGR1BP CNTN3 IGSF9B CD200R1L USH2A FCAMR MYBPC1 MYBPC3 | 1.09e-06 | 706 | 125 | 18 | IPR013783 |
| Domain | - | IL11RA HSPG2 MXRA5 HLA-DRA INSRR SIGLEC14 LRRN3 FCGR1A IGFBP7 FCGR1BP CNTN3 IGSF9B CD200R1L USH2A FCAMR MYBPC1 MYBPC3 | 2.07e-06 | 663 | 125 | 17 | 2.60.40.10 |
| Domain | UDPGT | 1.05e-05 | 21 | 125 | 4 | PF00201 | |
| Domain | UDPGT | 1.05e-05 | 21 | 125 | 4 | PS00375 | |
| Domain | UDP_glucos_trans | 1.05e-05 | 21 | 125 | 4 | IPR002213 | |
| Domain | fn3 | 1.34e-05 | 162 | 125 | 8 | PF00041 | |
| Domain | FN3 | 3.49e-05 | 185 | 125 | 8 | SM00060 | |
| Domain | NPY4_rcpt | 4.44e-05 | 2 | 125 | 2 | IPR001933 | |
| Domain | SPIN-2 | 4.44e-05 | 2 | 125 | 2 | IPR029564 | |
| Domain | FN3 | 5.85e-05 | 199 | 125 | 8 | PS50853 | |
| Domain | FN3_dom | 8.25e-05 | 209 | 125 | 8 | IPR003961 | |
| Domain | Ig_2 | 1.29e-04 | 73 | 125 | 5 | PF13895 | |
| Domain | RNA_pol_Rpb1_2 | 1.33e-04 | 3 | 125 | 2 | PF00623 | |
| Domain | RNA_pol_asu | 1.33e-04 | 3 | 125 | 2 | IPR000722 | |
| Domain | RNA_pol_N | 1.33e-04 | 3 | 125 | 2 | IPR006592 | |
| Domain | RNA_pol_Rpb1_1 | 1.33e-04 | 3 | 125 | 2 | PF04997 | |
| Domain | RNA_pol_Rpb1_5 | 1.33e-04 | 3 | 125 | 2 | PF04998 | |
| Domain | RNA_pol_Rpb1_3 | 1.33e-04 | 3 | 125 | 2 | PF04983 | |
| Domain | RNA_pol_Rpb1_4 | 1.33e-04 | 3 | 125 | 2 | PF05000 | |
| Domain | RPOLA_N | 1.33e-04 | 3 | 125 | 2 | SM00663 | |
| Domain | RNA_pol_Rpb1_4 | 1.33e-04 | 3 | 125 | 2 | IPR007083 | |
| Domain | RNA_pol_Rpb1_5 | 1.33e-04 | 3 | 125 | 2 | IPR007081 | |
| Domain | RNA_pol_Rpb1_1 | 1.33e-04 | 3 | 125 | 2 | IPR007080 | |
| Domain | RNA_pol_Rpb1_3 | 1.33e-04 | 3 | 125 | 2 | IPR007066 | |
| Domain | LRR_8 | 1.54e-04 | 171 | 125 | 7 | PF13855 | |
| Domain | LRR_TYP | 1.90e-04 | 177 | 125 | 7 | SM00369 | |
| Domain | Leu-rich_rpt_typical-subtyp | 1.90e-04 | 177 | 125 | 7 | IPR003591 | |
| Domain | Ldl_recept_a | 2.30e-04 | 45 | 125 | 4 | PF00057 | |
| Domain | - | 2.51e-04 | 46 | 125 | 4 | 4.10.400.10 | |
| Domain | LDLRA_1 | 2.96e-04 | 48 | 125 | 4 | PS01209 | |
| Domain | LDrepeatLR_classA_rpt | 3.21e-04 | 49 | 125 | 4 | IPR002172 | |
| Domain | LDLa | 3.21e-04 | 49 | 125 | 4 | SM00192 | |
| Domain | LDLRA_2 | 3.21e-04 | 49 | 125 | 4 | PS50068 | |
| Domain | DHC_N1 | 1.21e-03 | 8 | 125 | 2 | PF08385 | |
| Domain | Dynein_heavy_dom-1 | 1.21e-03 | 8 | 125 | 2 | IPR013594 | |
| Domain | NPY_rcpt | 1.55e-03 | 9 | 125 | 2 | IPR000611 | |
| Domain | L_dom-like | 1.65e-03 | 328 | 125 | 8 | IPR032675 | |
| Domain | ig | 1.77e-03 | 190 | 125 | 6 | PF00047 | |
| Domain | Immunoglobulin | 1.77e-03 | 190 | 125 | 6 | IPR013151 | |
| Domain | LAM_G_DOMAIN | 2.08e-03 | 38 | 125 | 3 | PS50025 | |
| Domain | Leu-rich_rpt | 2.33e-03 | 271 | 125 | 7 | IPR001611 | |
| Domain | LRR | 2.34e-03 | 201 | 125 | 6 | PS51450 | |
| Domain | LDLR_class-A_CS | 2.41e-03 | 40 | 125 | 3 | IPR023415 | |
| Domain | Laminin_G_2 | 2.41e-03 | 40 | 125 | 3 | PF02210 | |
| Domain | - | 2.81e-03 | 12 | 125 | 2 | 3.40.50.1010 | |
| Domain | Peptidase_M1 | 2.81e-03 | 12 | 125 | 2 | IPR001930 | |
| Domain | LamG | 3.17e-03 | 44 | 125 | 3 | SM00282 | |
| Domain | Peptidase_M1_N | 3.30e-03 | 13 | 125 | 2 | IPR014782 | |
| Domain | Peptidase_M1 | 3.30e-03 | 13 | 125 | 2 | PF01433 | |
| Domain | LRR_1 | 3.58e-03 | 219 | 125 | 6 | PF00560 | |
| Domain | Dynein_heavy_chain_D4_dom | 3.84e-03 | 14 | 125 | 2 | IPR024317 | |
| Domain | Dynein_HC_stalk | 3.84e-03 | 14 | 125 | 2 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 3.84e-03 | 14 | 125 | 2 | IPR013602 | |
| Domain | DHC_N2 | 3.84e-03 | 14 | 125 | 2 | PF08393 | |
| Domain | ATPase_dyneun-rel_AAA | 3.84e-03 | 14 | 125 | 2 | IPR011704 | |
| Domain | PIN_domain-like | 3.84e-03 | 14 | 125 | 2 | IPR029060 | |
| Domain | MT | 3.84e-03 | 14 | 125 | 2 | PF12777 | |
| Domain | AAA_8 | 3.84e-03 | 14 | 125 | 2 | PF12780 | |
| Domain | AAA_5 | 3.84e-03 | 14 | 125 | 2 | PF07728 | |
| Domain | ZINC_PROTEASE | 4.26e-03 | 98 | 125 | 4 | PS00142 | |
| Domain | DHC_fam | 4.41e-03 | 15 | 125 | 2 | IPR026983 | |
| Domain | Dynein_heavy | 4.41e-03 | 15 | 125 | 2 | PF03028 | |
| Domain | Dynein_heavy_dom | 4.41e-03 | 15 | 125 | 2 | IPR004273 | |
| Domain | PlsC | 5.66e-03 | 17 | 125 | 2 | SM00563 | |
| Domain | Plipid/glycerol_acylTrfase | 5.66e-03 | 17 | 125 | 2 | IPR002123 | |
| Domain | Thioredoxin_CS | 5.66e-03 | 17 | 125 | 2 | IPR017937 | |
| Domain | - | 5.89e-03 | 321 | 125 | 7 | 3.80.10.10 | |
| Pathway | REACTOME_GLUCURONIDATION | 8.47e-06 | 24 | 78 | 4 | MM14599 | |
| Pathway | KEGG_STARCH_AND_SUCROSE_METABOLISM | 9.66e-06 | 52 | 78 | 5 | M14171 | |
| Pathway | REACTOME_GLUCURONIDATION | 1.00e-05 | 25 | 78 | 4 | M17787 | |
| Pathway | WP_GLUCURONIDATION | 1.00e-05 | 25 | 78 | 4 | MM15820 | |
| Pathway | KEGG_ASCORBATE_AND_ALDARATE_METABOLISM | 1.00e-05 | 25 | 78 | 4 | M605 | |
| Pathway | WP_GLUCURONIDATION | 1.18e-05 | 26 | 78 | 4 | M39404 | |
| Pathway | KEGG_PENTOSE_AND_GLUCURONATE_INTERCONVERSIONS | 1.61e-05 | 28 | 78 | 4 | M19580 | |
| Pathway | REACTOME_ATORVASTATIN_ADME | 7.07e-05 | 15 | 78 | 3 | MM15697 | |
| Pathway | KEGG_PORPHYRIN_AND_CHLOROPHYLL_METABOLISM | 7.52e-05 | 41 | 78 | 4 | M7399 | |
| Pathway | REACTOME_ASPIRIN_ADME | 9.95e-05 | 44 | 78 | 4 | M45014 | |
| Pathway | REACTOME_ASPIRIN_ADME | 1.09e-04 | 45 | 78 | 4 | MM15694 | |
| Pathway | REACTOME_HEME_DEGRADATION | 1.74e-04 | 20 | 78 | 3 | MM14721 | |
| Pathway | KEGG_DRUG_METABOLISM_OTHER_ENZYMES | 1.78e-04 | 51 | 78 | 4 | M17726 | |
| Pathway | KEGG_STEROID_HORMONE_BIOSYNTHESIS | 2.39e-04 | 55 | 78 | 4 | M14933 | |
| Pathway | REACTOME_PREDNISONE_ADME | 2.66e-04 | 23 | 78 | 3 | MM16639 | |
| Pathway | KEGG_RETINOL_METABOLISM | 4.28e-04 | 64 | 78 | 4 | M9488 | |
| Pathway | KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450 | 6.03e-04 | 70 | 78 | 4 | M16794 | |
| Pathway | KEGG_DRUG_METABOLISM_CYTOCHROME_P450 | 6.71e-04 | 72 | 78 | 4 | M9257 | |
| Pathway | REACTOME_METABOLISM_OF_PORPHYRINS | 7.20e-04 | 32 | 78 | 3 | MM14719 | |
| Pubmed | A transcriptional coregulator, SPIN·DOC, attenuates the coactivator activity of Spindlin1. | 2.87e-09 | 6 | 131 | 4 | 29061846 | |
| Pubmed | 3.97e-08 | 10 | 131 | 4 | 23064749 | ||
| Pubmed | 9.30e-08 | 12 | 131 | 4 | 14557543 | ||
| Pubmed | 2.08e-07 | 4 | 131 | 3 | 22419166 | ||
| Pubmed | Quantitation of HERV-K env gene expression and splicing in human breast cancer. | 5.19e-07 | 5 | 131 | 3 | 12629516 | |
| Pubmed | A revised nomenclature for transcribed human endogenous retroviral loci. | 1.58e-06 | 94 | 131 | 6 | 21542922 | |
| Pubmed | 1.93e-06 | 24 | 131 | 4 | 33722704 | ||
| Pubmed | 4.31e-06 | 9 | 131 | 3 | 22511988 | ||
| Pubmed | 4.31e-06 | 9 | 131 | 3 | 1339448 | ||
| Pubmed | 6.15e-06 | 10 | 131 | 3 | 23642732 | ||
| Pubmed | 6.15e-06 | 10 | 131 | 3 | 11465080 | ||
| Pubmed | 6.15e-06 | 10 | 131 | 3 | 23371916 | ||
| Pubmed | A genome-wide association study of total bilirubin and cholelithiasis risk in sickle cell anemia. | 6.15e-06 | 10 | 131 | 3 | 22558097 | |
| Pubmed | 6.15e-06 | 10 | 131 | 3 | 12970426 | ||
| Pubmed | 1.12e-05 | 12 | 131 | 3 | 19419973 | ||
| Pubmed | Thirteen UDPglucuronosyltransferase genes are encoded at the human UGT1 gene complex locus. | 1.12e-05 | 12 | 131 | 3 | 11434514 | |
| Pubmed | 1.41e-05 | 2 | 131 | 2 | 28814603 | ||
| Pubmed | Features and protective efficacy of human mAbs targeting Mycobacterium tuberculosis arabinomannan. | 1.41e-05 | 2 | 131 | 2 | 37733444 | |
| Pubmed | 1.41e-05 | 2 | 131 | 2 | 28289219 | ||
| Pubmed | 1.41e-05 | 2 | 131 | 2 | 31082373 | ||
| Pubmed | Amelioration of Lupus Serum-Induced Skin Inflammation in CD64-Deficient Mice. | 1.41e-05 | 2 | 131 | 2 | 35273604 | |
| Pubmed | 1.41e-05 | 2 | 131 | 2 | 12628722 | ||
| Pubmed | IgG3-mediated enhancement of the antibody response is normal in Fc gammaRI-deficient mice. | 1.41e-05 | 2 | 131 | 2 | 16305642 | |
| Pubmed | 1.41e-05 | 2 | 131 | 2 | 9257847 | ||
| Pubmed | 1.41e-05 | 2 | 131 | 2 | 21124939 | ||
| Pubmed | 1.41e-05 | 2 | 131 | 2 | 8068691 | ||
| Pubmed | Macrophages eliminate circulating tumor cells after monoclonal antibody therapy. | 1.41e-05 | 2 | 131 | 2 | 24430180 | |
| Pubmed | Expression of modified FcγRI enables myeloid cells to elicit robust tumor-specific cytotoxicity. | 1.41e-05 | 2 | 131 | 2 | 38885133 | |
| Pubmed | Novel Fc gamma receptor I family gene products in human mononuclear cells. | 1.41e-05 | 2 | 131 | 2 | 1430234 | |
| Pubmed | Developmental expression of HERV-R (ERV3) and HERV-K in human tissue. | 1.41e-05 | 2 | 131 | 2 | 12083821 | |
| Pubmed | 1.41e-05 | 2 | 131 | 2 | 15835266 | ||
| Pubmed | 1.41e-05 | 2 | 131 | 2 | 8663283 | ||
| Pubmed | 1.41e-05 | 2 | 131 | 2 | 25231998 | ||
| Pubmed | 1.41e-05 | 2 | 131 | 2 | 30190171 | ||
| Pubmed | 1.41e-05 | 2 | 131 | 2 | 24641623 | ||
| Pubmed | 1.41e-05 | 2 | 131 | 2 | 9060628 | ||
| Pubmed | Molecular cloning and expression of the mouse high affinity Fc receptor for IgG. | 1.41e-05 | 2 | 131 | 2 | 2136886 | |
| Pubmed | Evolutionary relationships within a subgroup of HERV-K-related human endogenous retroviruses. | 1.41e-05 | 2 | 131 | 2 | 9460924 | |
| Pubmed | 1.41e-05 | 2 | 131 | 2 | 1830050 | ||
| Pubmed | FcRγ deficiency improves survival in experimental sepsis by down-regulating TLR4 signaling pathway. | 1.41e-05 | 2 | 131 | 2 | 30552619 | |
| Pubmed | Sensory Neuron Expressed FcγRI Mediates Postinflammatory Arthritis Pain in Female Mice. | 1.41e-05 | 2 | 131 | 2 | 35833115 | |
| Pubmed | Differential gene expression modulated by the cytoplasmic domain of Fc gamma RIa (CD64) alpha-chain. | 1.41e-05 | 2 | 131 | 2 | 15528358 | |
| Pubmed | Functional characteristics of the high affinity IgG receptor, FcγRI. | 1.41e-05 | 2 | 131 | 2 | 21325219 | |
| Pubmed | Fc receptors and the common gamma-chain in experimental autoimmune encephalomyelitis. | 1.41e-05 | 2 | 131 | 2 | 14991835 | |
| Pubmed | 1.41e-05 | 2 | 131 | 2 | 1402657 | ||
| Pubmed | 1.41e-05 | 2 | 131 | 2 | 8611682 | ||
| Pubmed | 1.41e-05 | 2 | 131 | 2 | 16409296 | ||
| Pubmed | Mouse FcgammaRI: identification and functional characterization of five new alleles. | 1.41e-05 | 2 | 131 | 2 | 10752630 | |
| Pubmed | 1.41e-05 | 2 | 131 | 2 | 30744065 | ||
| Pubmed | Serum anti-Fcgamma receptor autoantibodies in patients with alopecia areata. | 1.41e-05 | 2 | 131 | 2 | 17124586 | |
| Pubmed | 1.41e-05 | 2 | 131 | 2 | 31211699 | ||
| Pubmed | Linkage on chromosome 3 of autoimmune diabetes and defective Fc receptor for IgG in NOD mice. | 1.41e-05 | 2 | 131 | 2 | 8480181 | |
| Pubmed | Functional cloning of SPIN-2, a nuclear anti-apoptotic protein with roles in cell cycle progression. | 1.41e-05 | 2 | 131 | 2 | 12145692 | |
| Pubmed | Fc Effector Function Contributes to the Activity of Human Anti-CTLA-4 Antibodies. | 1.41e-05 | 2 | 131 | 2 | 29576375 | |
| Pubmed | 1.41e-05 | 2 | 131 | 2 | 18245810 | ||
| Pubmed | 1.41e-05 | 2 | 131 | 2 | 16849450 | ||
| Pubmed | 1.41e-05 | 2 | 131 | 2 | 8478020 | ||
| Pubmed | FcγR-binding affinity of monoclonal murine IgG1s carrying different N-linked Fc oligosaccharides. | 1.41e-05 | 2 | 131 | 2 | 31554601 | |
| Pubmed | Double mutations in klotho and osteoprotegerin gene loci rescued osteopetrotic phenotype. | 1.41e-05 | 2 | 131 | 2 | 12446599 | |
| Pubmed | 1.41e-05 | 2 | 131 | 2 | 38524127 | ||
| Pubmed | 1.41e-05 | 2 | 131 | 2 | 8077658 | ||
| Pubmed | 1.41e-05 | 2 | 131 | 2 | 14570768 | ||
| Pubmed | The involvement of FcR mechanisms in antibody-mediated rejection. | 1.41e-05 | 2 | 131 | 2 | 18049118 | |
| Pubmed | UGT1A1 is a major locus influencing bilirubin levels in African Americans. | 1.45e-05 | 13 | 131 | 3 | 22085899 | |
| Pubmed | Genome-wide analysis of hepatic lipid content in extreme obesity. | 1.45e-05 | 13 | 131 | 3 | 25246029 | |
| Pubmed | TRAF4 acts as a silencer in TLR-mediated signaling through the association with TRAF6 and TRIF. | 1.45e-05 | 13 | 131 | 3 | 16052631 | |
| Pubmed | 1.84e-05 | 14 | 131 | 3 | 21646302 | ||
| Pubmed | Human UDP-glucuronosyltransferases: metabolism, expression, and disease. | 1.84e-05 | 14 | 131 | 3 | 10836148 | |
| Pubmed | Multiple variable first exons: a mechanism for cell- and tissue-specific gene regulation. | 1.84e-05 | 14 | 131 | 3 | 14672974 | |
| Pubmed | 1.84e-05 | 14 | 131 | 3 | 9295054 | ||
| Pubmed | 2.82e-05 | 16 | 131 | 3 | 15878328 | ||
| Pubmed | Genome-wide association meta-analysis for total serum bilirubin levels. | 2.82e-05 | 16 | 131 | 3 | 19414484 | |
| Pubmed | Genome-wide association of serum bilirubin levels in Korean population. | 3.42e-05 | 17 | 131 | 3 | 20639394 | |
| Pubmed | Neonatal Fc receptor for IgG regulates mucosal immune responses to luminal bacteria. | 4.21e-05 | 3 | 131 | 2 | 16841095 | |
| Pubmed | 4.21e-05 | 3 | 131 | 2 | 12427132 | ||
| Pubmed | MicroRNA-127 inhibits lung inflammation by targeting IgG Fcγ receptor I. | 4.21e-05 | 3 | 131 | 2 | 22287715 | |
| Pubmed | Tpl2 kinase regulates FcγR signaling and immune thrombocytopenia in mice. | 4.21e-05 | 3 | 131 | 2 | 23898046 | |
| Pubmed | 4.21e-05 | 3 | 131 | 2 | 22003208 | ||
| Pubmed | 4.21e-05 | 3 | 131 | 2 | 10516026 | ||
| Pubmed | 4.21e-05 | 3 | 131 | 2 | 12594281 | ||
| Pubmed | 4.21e-05 | 3 | 131 | 2 | 12051676 | ||
| Pubmed | 4.21e-05 | 3 | 131 | 2 | 15880819 | ||
| Pubmed | 4.21e-05 | 3 | 131 | 2 | 28924242 | ||
| Pubmed | 4.21e-05 | 3 | 131 | 2 | 9892619 | ||
| Pubmed | 4.21e-05 | 3 | 131 | 2 | 30636035 | ||
| Pubmed | 4.21e-05 | 3 | 131 | 2 | 26056254 | ||
| Pubmed | The essential role of complement in antibody-mediated resistance to Salmonella. | 4.21e-05 | 3 | 131 | 2 | 30179254 | |
| Pubmed | 4.21e-05 | 3 | 131 | 2 | 8697799 | ||
| Pubmed | 4.21e-05 | 3 | 131 | 2 | 23728777 | ||
| Pubmed | 4.21e-05 | 3 | 131 | 2 | 23223146 | ||
| Pubmed | FcγRI mediates serum amyloid P inhibition of fibrocyte differentiation. | 4.21e-05 | 3 | 131 | 2 | 22493081 | |
| Pubmed | 4.21e-05 | 3 | 131 | 2 | 16543474 | ||
| Pubmed | Genome-Wide Detection of Copy Number Variations in Unsolved Inherited Retinal Disease. | 4.21e-05 | 3 | 131 | 2 | 28118666 | |
| Pubmed | 4.21e-05 | 3 | 131 | 2 | 24161960 | ||
| Pubmed | 4.21e-05 | 3 | 131 | 2 | 12707052 | ||
| Pubmed | 4.21e-05 | 3 | 131 | 2 | 19657115 | ||
| Pubmed | Fc-optimized antibodies elicit CD8 immunity to viral respiratory infection. | 4.21e-05 | 3 | 131 | 2 | 33032297 | |
| Pubmed | 4.21e-05 | 3 | 131 | 2 | 9763663 | ||
| Pubmed | C1q-Dependent Dendritic Cell Cross-Presentation of In Vivo-Formed Antigen-Antibody Complexes. | 4.21e-05 | 3 | 131 | 2 | 28432146 | |
| Pubmed | Cloning and functional expression of cDNAs encoding human and rat pancreatic polypeptide receptors. | 4.21e-05 | 3 | 131 | 2 | 8643460 | |
| Cytoband | Xp11.1 | 4.76e-05 | 4 | 130 | 2 | Xp11.1 | |
| Cytoband | 2q37 | 9.41e-05 | 31 | 130 | 3 | 2q37 | |
| GeneFamily | Tudor domain containing|Spindlin family | 1.86e-09 | 5 | 81 | 4 | 1089 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 4.24e-08 | 161 | 81 | 9 | 593 | |
| GeneFamily | Fibronectin type III domain containing | 5.87e-07 | 160 | 81 | 8 | 555 | |
| GeneFamily | Immunoglobulin like domain containing | 2.41e-06 | 193 | 81 | 8 | 594 | |
| GeneFamily | UDP glucuronosyltransferases | 1.22e-05 | 32 | 81 | 4 | 363 | |
| GeneFamily | Tudor domain containing | 2.21e-05 | 37 | 81 | 4 | 780 | |
| GeneFamily | Fibronectin type III domain containing|I-set domain containing|Myosin binding proteins | 5.45e-04 | 8 | 81 | 2 | 658 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.73e-07 | 160 | 126 | 7 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.73e-07 | 160 | 126 | 7 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.56e-07 | 184 | 126 | 7 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.56e-07 | 184 | 126 | 7 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.56e-07 | 184 | 126 | 7 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | facs-Lung-nan-3m-Endothelial-Capillary_Aerocyte_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.14e-06 | 189 | 126 | 7 | 09dd2b3d89416192e84abe302a6237b8f3fdcb6e | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.14e-06 | 189 | 126 | 7 | 203c80030df08ae112f9ae4043709f455d87ce89 | |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.51e-06 | 197 | 126 | 7 | bf0520a94ebb1d2f94de9f526d17e0b0e8fe7052 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_COL|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.56e-06 | 198 | 126 | 7 | 8b9e8eaeffda40912a0163fdf39b93bc5e64751c | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-Neuronal-Intermediate|10w / Sample Type, Dataset, Time_group, and Cell type. | 1.67e-06 | 200 | 126 | 7 | e5a8647c47a49c8c90c78d681193946de103d8ff | |
| ToppCell | facs-Marrow-B-cells-24m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.06e-05 | 175 | 126 | 6 | 887e75fc90e59a6394d62f3c048a9cfdf6707725 | |
| ToppCell | E16.5-Epithelial-Epithelial_Airway-Neurosecretory-PNEC-PNEC_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.17e-05 | 178 | 126 | 6 | d3a75a8082e70543b84c35d53fe77625300d19fa | |
| ToppCell | E16.5-Epithelial-Epithelial_Airway-Neurosecretory-PNEC|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.17e-05 | 178 | 126 | 6 | b2cda1df801b1a1a41e3dd2808baef37765cd804 | |
| ToppCell | metastatic_Brain-Fibroblasts-Myofibroblasts|metastatic_Brain / Location, Cell class and cell subclass | 1.29e-05 | 181 | 126 | 6 | bd0b5f74f9c81ec0f1592710774a4fdf33d9d5a9 | |
| ToppCell | PND10-Epithelial-Epithelial_Airway-Neurosecretory-PNEC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.33e-05 | 182 | 126 | 6 | 1923932a9c60e9ec33db69ded441210d1fb07bec | |
| ToppCell | PND10-Epithelial-Epithelial_Airway-Neurosecretory-PNEC-PNEC_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.33e-05 | 182 | 126 | 6 | 69ff652f74cc47fbe0bd665ab17c445c5b959dad | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Endothelial-blood_vessel_EC|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.55e-05 | 187 | 126 | 6 | 0ef82111b9049cc7ee78d64d240e1f10ab14d6b6 | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|LA / Chamber and Cluster_Paper | 1.60e-05 | 188 | 126 | 6 | 34e1b074a3995aa46ab194eb45115d76d1a5514d | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 1.65e-05 | 189 | 126 | 6 | 6b3e88751b95fc2173f2c3d5061ed632d0c5f01c | |
| ToppCell | Mesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor | 1.85e-05 | 193 | 126 | 6 | acad568621ed677031797b8c2e34dafea798d681 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.91e-05 | 194 | 126 | 6 | 011e14d9ed1393275f892060e7708ffadcd0767f | |
| ToppCell | Control-Fibroblasts-Intermediate_pathological_FB|Control / group, cell type (main and fine annotations) | 1.91e-05 | 194 | 126 | 6 | 03a269f75a481ea54aea8e6444605db8d6df493d | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.91e-05 | 194 | 126 | 6 | 35f132cc38ac133be01834ed0946188aa0757eb4 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.08e-05 | 197 | 126 | 6 | 0034bae02ee7fcfea520d453ca3c842ab6963b12 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.08e-05 | 197 | 126 | 6 | 11a4c417f035e554431a8f03be13b5eefa3530c0 | |
| ToppCell | background-Hepatic_Stellate_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 2.14e-05 | 198 | 126 | 6 | 79f32f965aed6a10c5cb803173e3db7b32e07a91 | |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.26e-05 | 200 | 126 | 6 | a66449b22b39dd6987fc2c3ed160d24564234ced | |
| ToppCell | cellseq2-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel-SVEC|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.26e-05 | 200 | 126 | 6 | 147ceed692655f4ed73b8a57b0b3224def1f3055 | |
| ToppCell | droplet-Liver-LIVER-NPC-1m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.47e-05 | 153 | 126 | 5 | a8f83ec640fae51d4fba34b92e3d6cca4999e930 | |
| ToppCell | droplet-Liver-Hepatocytes-21m-Lymphocytic-NK/T|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.78e-05 | 162 | 126 | 5 | eb2900a250fb3e08e479c727c7d3200cbcf37fbc | |
| ToppCell | droplet-Liver-Hepatocytes-21m-Lymphocytic-NK_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.78e-05 | 162 | 126 | 5 | 1ef3084b5766641ec07c6f488c1756239cf3fd61 | |
| ToppCell | facs-Skin-Anagen-24m-Epithelial-bulge_keratinocyte|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.13e-04 | 167 | 126 | 5 | 78909f685ccd1321064eb0887caf9263e0e54879 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-C_(Myofibroblast)|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.16e-04 | 168 | 126 | 5 | 1bc6a1915d48f547385ed4f44e118bcc8a4a7b6c | |
| ToppCell | 368C-Fibroblasts-Fibroblast-C_(Myofibroblast)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.16e-04 | 168 | 126 | 5 | 69f534de0f9a293047bea03cb1b78551087a8df5 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Myeloid-Monocytic-Classical_Monocyte-Mono_c2-CD14-HLA-DPB1|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.19e-04 | 169 | 126 | 5 | d4bd489ebdb86e70ed5e3dbbe8518c6cae2197e5 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal--glomerular_mesenchymal_cell-Renin-positive_Juxtaglomerular_Granular_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.23e-04 | 170 | 126 | 5 | 99dd734c0972a40d5381e8e2d96bdaa31f6d06e6 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal--glomerular_mesenchymal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.23e-04 | 170 | 126 | 5 | 3a14eeae221b8bb0bd0dadcb8e7a603431240a1e | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.23e-04 | 170 | 126 | 5 | cdb6fad277f284c3fd5a6f45672a8edc24715882 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-H-|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.37e-04 | 174 | 126 | 5 | 2627c3983009839fedbc5e3f628739dc026447f4 | |
| ToppCell | TCGA-Breast-Solid_Tissue_Normal-Breast_normal_tissue-Breast_normal_tissue-3|TCGA-Breast / Sample_Type by Project: Shred V9 | 1.37e-04 | 174 | 126 | 5 | 7f8f5fafae08676d2b90cab9802c3c9320f1370e | |
| ToppCell | TCGA-Breast-Solid_Tissue_Normal|TCGA-Breast / Sample_Type by Project: Shred V9 | 1.37e-04 | 174 | 126 | 5 | e2f240d60bffbe8e6d60f0bb405b231bd3c96875 | |
| ToppCell | TCGA-Breast-Solid_Tissue_Normal-Breast_normal_tissue-Breast_normal_tissue|TCGA-Breast / Sample_Type by Project: Shred V9 | 1.37e-04 | 174 | 126 | 5 | 0f3ec0d0d4344e10c9b48adc9174123f6402dc51 | |
| ToppCell | TCGA-Breast-Solid_Tissue_Normal-Breast_normal_tissue|TCGA-Breast / Sample_Type by Project: Shred V9 | 1.37e-04 | 174 | 126 | 5 | 1aadbf2642b6d1320ceabd92e6ff59e11f16c315 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-H|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.37e-04 | 174 | 126 | 5 | 507a33e58f62e2b72f0bcc743e84dbd0bf705a15 | |
| ToppCell | TCGA-Head_and_Esophagus-Primary_Tumor-Esophageal_Carcinoma-Esophagus_Squamous_Cell_Carcinoma-7|TCGA-Head_and_Esophagus / Sample_Type by Project: Shred V9 | 1.41e-04 | 93 | 126 | 4 | 4ab8c28f7c47129ac633bcfdc7ccc8f7793464d5 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.44e-04 | 176 | 126 | 5 | c6484334187f64cd00cd35e77d8ae436556b4260 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.44e-04 | 176 | 126 | 5 | 87de432c680b80555342afac864599bbc002c040 | |
| ToppCell | PND07-28-samps-Mesenchymal-Myofibroblast-myofibroblast_-_mature_-_DCN|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 1.44e-04 | 176 | 126 | 5 | 08f94b78b27feeb113dbfadbfa7fe34d08b2809b | |
| ToppCell | tumor_Lung-Endothelial_cells-EPCs|tumor_Lung / Location, Cell class and cell subclass | 1.48e-04 | 177 | 126 | 5 | f8b152c09d56a97e8c0482fb1a3964c05f9dc8c5 | |
| ToppCell | 368C-Myeloid-Macrophage-SPP1+_Macrophage_3|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.52e-04 | 178 | 126 | 5 | 9d575902d3dbe33437c9d4200df093a741269803 | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.52e-04 | 178 | 126 | 5 | 41745a589567ca5ea6d06331f4c8da03595b5f5c | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.52e-04 | 178 | 126 | 5 | eb940dd64c973f68bcaad6069d3bd56383329db5 | |
| ToppCell | PCW_05-06-Neuronal-Neuronal_postreplicative-neuro_migrating_neuronal_(3)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.52e-04 | 178 | 126 | 5 | 38ffbd01230c99f52274424ee6c172381daffc73 | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-Pericyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.56e-04 | 179 | 126 | 5 | 7078022e60faa86444f2a2c6eb9f767cc66b5cfa | |
| ToppCell | droplet-Bladder-BLADDER-1m-Epithelial-endothelial_cell|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.56e-04 | 179 | 126 | 5 | c7c74e26bbf86c5326ee38bac7de111d5414f46b | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-pericyte_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.56e-04 | 179 | 126 | 5 | d4a975d8ffa5e77fb5c0ec05bf9c8f843c77ce07 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-SMC_prolif|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.60e-04 | 180 | 126 | 5 | 64956a85c404a2ea7e4eaf6f95ebcc52c198b7cc | |
| ToppCell | renal_papilla_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 1.60e-04 | 180 | 126 | 5 | 49829e833fe6d2431cfd2e8f378c2aaa3b2b46a4 | |
| ToppCell | 3'_v3-bone_marrow-Mast|bone_marrow / Manually curated celltypes from each tissue | 1.60e-04 | 180 | 126 | 5 | b37ee81b792213d6595b4ec65d04bc35d83321c7 | |
| ToppCell | Control-Fibroblasts-Airway_smooth_muscle|Control / group, cell type (main and fine annotations) | 1.60e-04 | 180 | 126 | 5 | d0de12749ef0f51f0931c6e7b9b99966bdbc3ec1 | |
| ToppCell | 3'_v3-bone_marrow-Mast-Mast_cells|bone_marrow / Manually curated celltypes from each tissue | 1.64e-04 | 181 | 126 | 5 | 30ec4635474ee0f0ea1415ec0ba7f008d97e8c1a | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.64e-04 | 181 | 126 | 5 | 9ede19228ba5c0668a9c06c915510b95585216ef | |
| ToppCell | Adult-Mesenchymal-airway_smooth_muscle_cell-D175|Adult / Lineage, Cell type, age group and donor | 1.69e-04 | 182 | 126 | 5 | ad4d74d8b19976e1ccc3c5ba8013199338cf6fd8 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.5.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.73e-04 | 183 | 126 | 5 | 103c4c4595d8daa677679fd2fa1e99cd398e56dd | |
| ToppCell | RA-13._Vascular_Smooth_Muscle|RA / Chamber and Cluster_Paper | 1.73e-04 | 183 | 126 | 5 | 818fd886e0188091310825f9145fa53328f2c979 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.73e-04 | 183 | 126 | 5 | b4f29dd3994009bb5eb769d36d95886664e7f87d | |
| ToppCell | RA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 1.73e-04 | 183 | 126 | 5 | cae2ee08f985a6f005b4b8e959e465350315156a | |
| ToppCell | (8)_CD34_progenitor|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 1.86e-04 | 186 | 126 | 5 | 943c604a7cd873faf510096d094100512ba2d6bc | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.86e-04 | 186 | 126 | 5 | bdbe290f81106a53c8c30a92fbb385597c62b2ac | |
| ToppCell | (8)_CD34_progenitor|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 1.86e-04 | 186 | 126 | 5 | e69a986b8618effd61875fda528a2e44aab11868 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.4.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.86e-04 | 186 | 126 | 5 | cb7df8da6478b96955f3ef1394a0655ec8061bba | |
| ToppCell | 10x3'2.3-week_17-19-Endothelial-stroma-proliferating_EC|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.86e-04 | 186 | 126 | 5 | a844d4f79e0ad5d6c60a4488ffd8f4f21b7eed04 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.91e-04 | 187 | 126 | 5 | f18628ffc7ff7c762b8339ba8822cf0c3157f469 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_vein|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.91e-04 | 187 | 126 | 5 | e35716f8b482be3bf5ab79f087a9caf67a9d197a | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D175|Adult / Lineage, Cell type, age group and donor | 1.91e-04 | 187 | 126 | 5 | e15d2967aac248da3517bc2c7d1beaa1d5a0aa7f | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_anti-infl-B|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.96e-04 | 188 | 126 | 5 | a9705f24e37b4aad8e42c9bf5bc1b9be2d01e761 | |
| ToppCell | wk_08-11-Epithelial-PNS-MFNG+_DBH+_neuron|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.96e-04 | 188 | 126 | 5 | d3d7d21d4fa39ac4106a164652673de1bef8662d | |
| ToppCell | Neuroendocrine-neuroendo-2-Calca|World / Class top | 2.01e-04 | 189 | 126 | 5 | 6baa9a74560121cc008bb8fa9b2b7a335b3aeee0 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.01e-04 | 189 | 126 | 5 | c3df0e3c50af8f1cfb4d790e668bd7f42b276992 | |
| ToppCell | PCW_13-14|World / Celltypes from embryonic and fetal-stage human lung | 2.06e-04 | 190 | 126 | 5 | 62a3ec1ae0829602b0569cc051210551644f1d46 | |
| ToppCell | droplet-Lung-18m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l27|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.06e-04 | 190 | 126 | 5 | 3cf464664d6aa22b212e60b70885953887e92483 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.11e-04 | 191 | 126 | 5 | 9431ffd6b758f756609d9057de2023596e22b5d4 | |
| ToppCell | metastatic_Lymph_Node-Fibroblasts-Myofibroblasts|metastatic_Lymph_Node / Location, Cell class and cell subclass | 2.11e-04 | 191 | 126 | 5 | aa43b472bc8362f79ae63f09f1ca764718bbf22c | |
| ToppCell | tumor_Lung-Myeloid_cells-Alveolar_Mac|tumor_Lung / Location, Cell class and cell subclass | 2.16e-04 | 192 | 126 | 5 | 44eda67501e69799c5981be602c143d12f5f222f | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.16e-04 | 192 | 126 | 5 | 29bee88b45e23f16543ffc7cc361bc5da5d16a2b | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_aging_sig-C|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.16e-04 | 192 | 126 | 5 | 4037b4c4fbb40541b8c424c36d3871a57891b8dd | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.16e-04 | 192 | 126 | 5 | cdc652dbfabe41b324fd85c1ed933d29fb73a49f | |
| ToppCell | (3)_Macrophage_MARCOpos|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 2.16e-04 | 192 | 126 | 5 | b1e2175bd4c02106e52d8f491eea1329ac327ae9 | |
| ToppCell | Neuroendocrine|World / Class top | 2.16e-04 | 192 | 126 | 5 | 0199da3ef9ddb6673e9aa41f346f374838aec182 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Oligodendroglioma-11|TCGA-Brain / Sample_Type by Project: Shred V9 | 2.17e-04 | 104 | 126 | 4 | 5114600bbadb5a0d31c164afd2e8c2a7865a1423 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-OPC-like-OPC-like-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.21e-04 | 193 | 126 | 5 | 315840bc48899f3a36d57b19197509de19716e3d | |
| ToppCell | Tracheal-NucSeq-Stromal-Peri/Epineurial_-NAF_endoneurial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.21e-04 | 193 | 126 | 5 | 549a0b750c860b615aff767ad04c9a9d20f802f0 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.21e-04 | 193 | 126 | 5 | 471e65f02937bc18d7c5facdacdf1df58cf0f839 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.21e-04 | 193 | 126 | 5 | fe451b3295d77b2bd1ac25cf29310c85835a45fe | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-2M-Mesenchymal|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type. | 2.27e-04 | 194 | 126 | 5 | 638b9fdce64ed00243b5303800ec66207d5fd640 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-2M-Mesenchymal-choroid_plexus/mesenchymal-like_cells|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type. | 2.27e-04 | 194 | 126 | 5 | e9868c22934b6c0ac35e3e8270ec0b671bc6582a | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.27e-04 | 194 | 126 | 5 | b1bb0f846d2865efdd9bc8842b16b9d069785882 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_adventitial_fibro_(9)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.27e-04 | 194 | 126 | 5 | 99577a5a631e607b5abe7a1b0d8d6a5eabe50196 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_adventitial_fibro_(9)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.32e-04 | 195 | 126 | 5 | 70387a62f121f8c374dba1aca9ab65cfed6a0b10 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.32e-04 | 195 | 126 | 5 | 1cdf5f296029ae424d9dba42e86a6d111e4896e6 | |
| Drug | AC1NOWCJ | 1.36e-06 | 35 | 126 | 5 | CID005120112 | |
| Drug | ApApG | 2.58e-06 | 18 | 126 | 4 | CID003081975 | |
| Drug | C1 11-32 | 2.58e-06 | 18 | 126 | 4 | CID000443077 | |
| Drug | C11131 | 2.58e-06 | 18 | 126 | 4 | CID000443076 | |
| Drug | harmol | 2.70e-06 | 40 | 126 | 5 | CID000068094 | |
| Drug | estriol-16-glucuronide | 4.98e-06 | 21 | 126 | 4 | CID000122281 | |
| Drug | N-methylpiperazine | 6.05e-06 | 22 | 126 | 4 | CID000053167 | |
| Drug | phenylbutazone | 6.79e-06 | 83 | 126 | 6 | CID000004781 | |
| Drug | estradiol-3-glucuronide | 7.30e-06 | 23 | 126 | 4 | CID000066651 | |
| Drug | AC1NQGK1 | 1.01e-05 | 52 | 126 | 5 | CID005195977 | |
| Drug | AC1MRQNQ | 1.36e-05 | 9 | 126 | 3 | CID003522271 | |
| Drug | DHPASiU | 1.36e-05 | 9 | 126 | 3 | CID000197602 | |
| Drug | 3-iodophenol | 1.36e-05 | 9 | 126 | 3 | CID000012272 | |
| Drug | AC1L4J7U | 1.36e-05 | 9 | 126 | 3 | CID000186631 | |
| Drug | Chebi:32663 | 1.36e-05 | 9 | 126 | 3 | CID005460873 | |
| Drug | Invader | 1.46e-05 | 56 | 126 | 5 | CID006442259 | |
| Drug | DB04103 | 1.67e-05 | 97 | 126 | 6 | CID004469987 | |
| Drug | phenolphthalein | 1.74e-05 | 58 | 126 | 5 | CID000004764 | |
| Drug | ABT-538 | 1.88e-05 | 148 | 126 | 7 | CID000005076 | |
| Drug | SN-38G | 1.89e-05 | 59 | 126 | 5 | CID000443154 | |
| Drug | AC1L1JAL | 1.91e-05 | 29 | 126 | 4 | CID000004954 | |
| Drug | 7-hydroxycoumarin glucuronide | 1.91e-05 | 29 | 126 | 4 | CID000125641 | |
| Drug | trans-3'-hydroxycotinine | 1.91e-05 | 29 | 126 | 4 | CID000000414 | |
| Drug | iberin | 1.91e-05 | 29 | 126 | 4 | CID000010455 | |
| Drug | paricalcitol | 2.19e-05 | 30 | 126 | 4 | CID005281104 | |
| Drug | 3-OHBaP | 2.61e-05 | 63 | 126 | 5 | CID000025890 | |
| Drug | 4-nitrophenyl)imidazole | 2.64e-05 | 11 | 126 | 3 | CID000123155 | |
| Drug | AC1O5XMV | 2.64e-05 | 11 | 126 | 3 | CID006442661 | |
| Drug | ketoprofen | 2.81e-05 | 64 | 126 | 5 | CID000003825 | |
| Drug | lithium indium | 3.04e-05 | 2 | 126 | 2 | CID011116062 | |
| Drug | scandium phosphate | 3.04e-05 | 2 | 126 | 2 | CID006365269 | |
| Drug | afloqualone | 3.04e-05 | 2 | 126 | 2 | ctd:C033541 | |
| Drug | rubidium nitrate | 3.04e-05 | 2 | 126 | 2 | CID000025731 | |
| Drug | R(-)-Denopamine | 3.23e-05 | 33 | 126 | 4 | CID000003818 | |
| Drug | AC1Q6OQG | 3.23e-05 | 33 | 126 | 4 | CID000009686 | |
| Drug | 6-methylsalicylic acid | 3.23e-05 | 33 | 126 | 4 | CID000011279 | |
| Drug | N-OH-DABZ | 3.51e-05 | 12 | 126 | 3 | CID000051366 | |
| Drug | 1-O-beta-D-glucopyranosyl-D-mannitol | 3.51e-05 | 12 | 126 | 3 | CID000088735 | |
| Drug | 2,4,6-TCB | 3.51e-05 | 12 | 126 | 3 | CID000037247 | |
| Drug | nonanoyl-N-methylglucamide | 3.51e-05 | 12 | 126 | 3 | CID000160090 | |
| Drug | 7,7,7-triphenylheptanoic acid | 3.51e-05 | 12 | 126 | 3 | CID000276709 | |
| Drug | Meldola | 3.78e-05 | 68 | 126 | 5 | CID000081507 | |
| Drug | 3-[(3S,5R,10S,13R,14S,17R)-3-[(2S,4R,5R,6S)-4,5-dihydroxy-6-methyloxan-2-yl]oxy-14-hydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-2H-furan-5-one | 4.10e-05 | 35 | 126 | 4 | CID010436171 | |
| Drug | estrone-3-glucuronide | 4.10e-05 | 35 | 126 | 4 | CID000115255 | |
| Drug | Azitidin | 4.41e-05 | 169 | 126 | 7 | CID000005726 | |
| Drug | tritanol | 4.55e-05 | 13 | 126 | 3 | CID000006457 | |
| Drug | 5-azido-UDP-glucuronic acid | 4.55e-05 | 13 | 126 | 3 | CID003081279 | |
| Drug | cotinine-N-glucuronide | 4.55e-05 | 13 | 126 | 3 | CID000000411 | |
| Drug | bevirimat | 4.59e-05 | 36 | 126 | 4 | CID000457928 | |
| Drug | l-borneol | 5.13e-05 | 37 | 126 | 4 | CID000010049 | |
| Drug | 4-methylumbelliferyl glucuronide | 5.71e-05 | 38 | 126 | 4 | CID000091553 | |
| Drug | propranolol glucuronide | 5.76e-05 | 14 | 126 | 3 | CID000119515 | |
| Drug | PCB-61 | 5.76e-05 | 14 | 126 | 3 | CID000036401 | |
| Drug | 4-nitrophenol | 5.91e-05 | 177 | 126 | 7 | CID000000980 | |
| Drug | 7-hydroxycoumarin | 6.07e-05 | 75 | 126 | 5 | CID005281426 | |
| Drug | thymoquinone | 7.00e-05 | 40 | 126 | 4 | CID000010281 | |
| Drug | 2,2',3,5,5'-pentachlorobiphenyl | 7.17e-05 | 15 | 126 | 3 | CID000040469 | |
| Drug | afloqualone | 7.17e-05 | 15 | 126 | 3 | CID000002040 | |
| Drug | naphthyl sulphate | 7.17e-05 | 15 | 126 | 3 | CID000114775 | |
| Drug | coumarin-3-carboxylic acid | 7.17e-05 | 15 | 126 | 3 | CID000010752 | |
| Drug | sulforaphane nitrile | 7.17e-05 | 15 | 126 | 3 | CID000543743 | |
| Drug | testosterone glucuronide | 7.73e-05 | 41 | 126 | 4 | CID000108192 | |
| Drug | quercetin-3,4'-diglucoside | 8.79e-05 | 16 | 126 | 3 | CID005320835 | |
| Drug | 1'-hydroxyestragole | 8.79e-05 | 16 | 126 | 3 | CID000040003 | |
| Drug | bilirubin-phosphate | 8.79e-05 | 16 | 126 | 3 | CID005497144 | |
| Drug | uridine 5'-diphosphoglucuronic acid | 8.93e-05 | 189 | 126 | 7 | CID000000390 | |
| Drug | cholesteryl linolenate | 9.08e-05 | 3 | 126 | 2 | CID000632727 | |
| Drug | androsterone glucuronide | 9.34e-05 | 43 | 126 | 4 | CID000114833 | |
| Drug | 3 beta,5 alpha,25R)- 3-hydroxyspirostan-12-one | 1.06e-04 | 17 | 126 | 3 | CID000003573 | |
| Drug | 6-hydroxychrysene | 1.06e-04 | 17 | 126 | 3 | CID000037766 | |
| Drug | ethyl acetate | 1.16e-04 | 137 | 126 | 6 | CID000008857 | |
| Drug | NSC626779 | 1.22e-04 | 46 | 126 | 4 | CID000116733 | |
| Drug | SureCN12722713 | 1.27e-04 | 18 | 126 | 3 | CID005488034 | |
| Drug | ethyl-beta-D-6-glucosiduronic acid | 1.27e-04 | 18 | 126 | 3 | CID000152226 | |
| Drug | Br 2 | 1.27e-04 | 18 | 126 | 3 | CID003060900 | |
| Drug | 2,3,7-trichlorodibenzo-p-dioxin | 1.27e-04 | 18 | 126 | 3 | CID000036614 | |
| Drug | 1-hydroxypyrene | 1.44e-04 | 48 | 126 | 4 | CID000021387 | |
| Drug | salicylamide | 1.44e-04 | 48 | 126 | 4 | CID000005147 | |
| Drug | 9-OH-risperidone | 1.50e-04 | 19 | 126 | 3 | CID000475100 | |
| Drug | 5alpha-spirostan-3beta-ol | 1.50e-04 | 19 | 126 | 3 | CID000091433 | |
| Drug | almokalant | 1.50e-04 | 19 | 126 | 3 | CID003033962 | |
| Drug | campestrol | 1.56e-04 | 49 | 126 | 4 | CID000010134 | |
| Drug | tectochrysin | 1.76e-04 | 20 | 126 | 3 | CID005281954 | |
| Drug | AC1L1OBF | 1.76e-04 | 20 | 126 | 3 | CID000032736 | |
| Drug | 4'-hydroxydiclofenac | 1.76e-04 | 20 | 126 | 3 | CID000116545 | |
| Drug | diphenylketen | 1.81e-04 | 4 | 126 | 2 | CID000013696 | |
| Drug | dulcin | 2.05e-04 | 21 | 126 | 3 | CID000009013 | |
| Drug | Benzamidoxime hydrochloride | 2.05e-04 | 21 | 126 | 3 | CID000069186 | |
| Drug | DEPC | 2.12e-04 | 53 | 126 | 4 | CID000015357 | |
| Drug | HCG 004 | 2.28e-04 | 54 | 126 | 4 | CID000064928 | |
| Drug | amonafide | 2.36e-04 | 22 | 126 | 3 | CID000050515 | |
| Drug | 3-hydroxyandrostan-17-one | 2.60e-04 | 102 | 126 | 5 | CID000000225 | |
| Drug | amidoxime | 2.70e-04 | 23 | 126 | 3 | CID000465967 | |
| Drug | phenanthridine | 2.70e-04 | 23 | 126 | 3 | CID000009189 | |
| Drug | 2,4,4'-trichlorobiphenyl | KNTC1 POLR1A STXBP5L FAT3 LMNTD2 URB2 FRY LRRN3 TRANK1 LRRC37A FCGR1A NALCN NPY4R MICAL2 SPIN1 IGSF9B POLQ DNAH8 GAA | 2.78e-04 | 1411 | 126 | 19 | ctd:C081766 |
| Drug | norclozapine | 2.82e-04 | 57 | 126 | 4 | CID000002820 | |
| Drug | magnesium perchlorate hexahydrate | 3.01e-04 | 5 | 126 | 2 | CID006431880 | |
| Drug | AS-3201 | 3.08e-04 | 24 | 126 | 3 | CID000153948 | |
| Drug | urochloralic acid | 3.22e-04 | 59 | 126 | 4 | CID003036914 | |
| Drug | 4-hydroxybiphenyl | 3.22e-04 | 59 | 126 | 4 | CID000007103 | |
| Disease | X-11793--oxidized bilirubin measurement | 3.99e-06 | 8 | 124 | 3 | EFO_0021260 | |
| Disease | Succinimide measurement | 3.99e-06 | 8 | 124 | 3 | EFO_0022118 | |
| Disease | X-11530 measurement | 3.99e-06 | 8 | 124 | 3 | EFO_0021249 | |
| Disease | sulfate of piperine metabolite C16H19NO3 (2) measurement | 3.99e-06 | 8 | 124 | 3 | EFO_0801034 | |
| Disease | cholelithiasis, bilirubin measurement | 3.99e-06 | 8 | 124 | 3 | EFO_0004570, EFO_0004799 | |
| Disease | X-11522 measurement | 3.99e-06 | 8 | 124 | 3 | EFO_0800696 | |
| Disease | X-10458 measurement | 3.99e-06 | 8 | 124 | 3 | EFO_0800692 | |
| Disease | X-24849 measurement | 3.99e-06 | 8 | 124 | 3 | EFO_0800909 | |
| Disease | membrane-associated progesterone receptor component 1 measurement | 3.99e-06 | 8 | 124 | 3 | EFO_0802740 | |
| Disease | X-16946 measurement | 3.99e-06 | 8 | 124 | 3 | EFO_0800766 | |
| Disease | Distal arthrogryposis | 5.97e-06 | 9 | 124 | 3 | cv:C0265213 | |
| Disease | X-11442 measurement | 5.97e-06 | 9 | 124 | 3 | EFO_0021236 | |
| Disease | X-11441 measurement | 5.97e-06 | 9 | 124 | 3 | EFO_0021235 | |
| Disease | circulating cell free DNA measurement | 5.97e-06 | 9 | 124 | 3 | EFO_0004739 | |
| Disease | sulfate of piperine metabolite C18H21NO3 (3) measurement | 5.97e-06 | 9 | 124 | 3 | EFO_0801037 | |
| Disease | sulfate of piperine metabolite C18H21NO3 (1) measurement | 5.97e-06 | 9 | 124 | 3 | EFO_0801036 | |
| Disease | X-11880 measurement | 5.97e-06 | 9 | 124 | 3 | EFO_0800698 | |
| Disease | protein-tyrosine kinase 6 measurement | 5.97e-06 | 9 | 124 | 3 | EFO_0020691 | |
| Disease | testis-specific chromodomain protein Y 1 measurement | 5.97e-06 | 9 | 124 | 3 | EFO_0802127 | |
| Disease | bilirubin measurement, response to xenobiotic stimulus | 5.97e-06 | 9 | 124 | 3 | EFO_0004570, GO_0009410 | |
| Disease | bilirubin measurement, response to tenofovir | 8.51e-06 | 10 | 124 | 3 | EFO_0004570, EFO_0009279 | |
| Disease | X-21448 measurement | 8.51e-06 | 10 | 124 | 3 | EFO_0800816 | |
| Disease | UDP-glucuronosyltransferase 1-6 measurement | 8.51e-06 | 10 | 124 | 3 | EFO_0802185 | |
| Disease | X-23974 measurement | 8.51e-06 | 10 | 124 | 3 | EFO_0800867 | |
| Disease | histidine betaine (hercynine) measurement | 1.17e-05 | 11 | 124 | 3 | EFO_0800972 | |
| Disease | X-21796 measurement | 1.17e-05 | 11 | 124 | 3 | EFO_0800825 | |
| Disease | insomnia, bilirubin measurement | 1.17e-05 | 11 | 124 | 3 | EFO_0004570, EFO_0004698 | |
| Disease | aldosterone measurement | 1.17e-05 | 11 | 124 | 3 | EFO_0010219 | |
| Disease | p-cresol glucuronide measurement | 1.55e-05 | 12 | 124 | 3 | EFO_0800079 | |
| Disease | biliverdin measurement | 1.55e-05 | 12 | 124 | 3 | EFO_0021033 | |
| Disease | retinol dehydrogenase 16 measurement | 2.01e-05 | 13 | 124 | 3 | EFO_0802007 | |
| Disease | low density lipoprotein cholesterol measurement, body fat percentage | 4.72e-05 | 17 | 124 | 3 | EFO_0004611, EFO_0007800 | |
| Disease | angiopoietin-related protein 1 measurement | 5.64e-05 | 18 | 124 | 3 | EFO_0801382 | |
| Disease | tissue factor measurement | 9.12e-05 | 21 | 124 | 3 | EFO_0010623 | |
| Disease | Endometrioid carcinoma ovary | 1.74e-04 | 5 | 124 | 2 | C0346163 | |
| Disease | Inguinal hernia | 2.19e-04 | 287 | 124 | 7 | HP_0000023 | |
| Disease | xanthurenate measurement | 2.44e-04 | 29 | 124 | 3 | EFO_0010551 | |
| Disease | Digitotalar Dysmorphism | 2.60e-04 | 6 | 124 | 2 | C1852085 | |
| Disease | ARTHROGRYPOSIS, DISTAL, TYPE 1 | 2.60e-04 | 6 | 124 | 2 | C0220662 | |
| Disease | response to dolutegravir | 2.71e-04 | 30 | 124 | 3 | EFO_0600017 | |
| Disease | vitamin D measurement | 5.63e-04 | 336 | 124 | 7 | EFO_0004631 | |
| Disease | Paranoia | 9.40e-04 | 11 | 124 | 2 | C1456784 | |
| Disease | pregnenetriol sulfate measurement | 9.40e-04 | 11 | 124 | 2 | EFO_0800586 | |
| Disease | plasma N-desmethylclozapine measurement | 9.40e-04 | 11 | 124 | 2 | EFO_0600039 | |
| Disease | Cardiomyopathy | 1.03e-03 | 47 | 124 | 3 | cv:C0878544 | |
| Disease | glucose measurement | 1.15e-03 | 380 | 124 | 7 | EFO_0004468 | |
| Disease | urate measurement, bone density | 1.24e-03 | 619 | 124 | 9 | EFO_0003923, EFO_0004531 | |
| Disease | response to trauma exposure | 1.30e-03 | 51 | 124 | 3 | EFO_0008483 | |
| Disease | pregnenetriol disulfate measurement | 1.33e-03 | 13 | 124 | 2 | EFO_0800587 | |
| Disease | Hypercalcemia | 1.33e-03 | 13 | 124 | 2 | C0020437 | |
| Disease | Milk-Alkali Syndrome | 1.33e-03 | 13 | 124 | 2 | C0026141 | |
| Disease | colonic neoplasm, overall survival | 1.54e-03 | 14 | 124 | 2 | EFO_0000638, EFO_0004288 | |
| Disease | psychosis | 1.54e-03 | 14 | 124 | 2 | EFO_0005407 | |
| Disease | distal arthrogryposis (implicated_via_orthology) | 1.77e-03 | 15 | 124 | 2 | DOID:0050646 (implicated_via_orthology) | |
| Disease | N-acetylmethionine measurement | 1.77e-03 | 15 | 124 | 2 | EFO_0021427 | |
| Disease | Hypertrophic Cardiomyopathy | 1.80e-03 | 57 | 124 | 3 | C0007194 | |
| Disease | urate measurement, spine bone mineral density | 1.89e-03 | 58 | 124 | 3 | EFO_0004531, EFO_0007701 | |
| Disease | Synostotic Posterior Plagiocephaly | 2.02e-03 | 16 | 124 | 2 | C1833340 | |
| Disease | Craniosynostosis, Type 1 | 2.02e-03 | 16 | 124 | 2 | C4551902 | |
| Disease | Acrocephaly | 2.02e-03 | 16 | 124 | 2 | C0030044 | |
| Disease | Trigonocephaly | 2.02e-03 | 16 | 124 | 2 | C0265535 | |
| Disease | Scaphycephaly | 2.02e-03 | 16 | 124 | 2 | C0265534 | |
| Disease | Synostotic Anterior Plagiocephaly | 2.02e-03 | 16 | 124 | 2 | C2931150 | |
| Disease | Metopic synostosis | 2.02e-03 | 16 | 124 | 2 | C1860819 | |
| Disease | Cardiomyopathies | 2.24e-03 | 130 | 124 | 4 | C0878544 | |
| Disease | Brachycephaly | 2.29e-03 | 17 | 124 | 2 | C0221356 | |
| Disease | X-21441 measurement | 2.29e-03 | 17 | 124 | 2 | EFO_0800814 | |
| Disease | mean corpuscular hemoglobin concentration | KNTC1 IRF2BP2 POLR1A LRRC37A2 MRPL30 FBRSL1 URB2 UGT2A3 C1orf105 SEC16A TXN2 GAA | 2.43e-03 | 1105 | 124 | 12 | EFO_0004528 |
| Disease | squamous cell carcinoma | 2.85e-03 | 67 | 124 | 3 | EFO_0000707 | |
| Disease | bipolar disorder (is_marker_for) | 2.86e-03 | 19 | 124 | 2 | DOID:3312 (is_marker_for) | |
| Disease | carotid artery disease (is_marker_for) | 2.86e-03 | 19 | 124 | 2 | DOID:3407 (is_marker_for) | |
| Disease | severe acute respiratory syndrome, COVID-19 | 2.88e-03 | 447 | 124 | 7 | EFO_0000694, MONDO_0100096 | |
| Disease | MHC class I polypeptide-related sequence A measurement | 2.97e-03 | 68 | 124 | 3 | EFO_0008233 | |
| Disease | Craniosynostosis | 3.17e-03 | 20 | 124 | 2 | C0010278 | |
| Disease | cortisol measurement | 3.17e-03 | 20 | 124 | 2 | EFO_0005843 | |
| Disease | cardiovascular disease | 3.25e-03 | 457 | 124 | 7 | EFO_0000319 | |
| Disease | Primary familial hypertrophic cardiomyopathy | 3.83e-03 | 22 | 124 | 2 | cv:C0949658 | |
| Disease | intellectual disability (implicated_via_orthology) | 3.92e-03 | 75 | 124 | 3 | DOID:1059 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SVQPWAESGKVLVVP | 21 | P35503 | |
| PPSQILDTWSLVLEK | 506 | Q14146 | |
| SLPVSLGPESWQQIA | 266 | Q9BXK5 | |
| KQTIWQLATEPTGPL | 166 | Q9NWW7 | |
| NLTILEPDQPIWTTG | 201 | Q14264 | |
| QLPPEIGSWKNITVL | 336 | Q96RT1 | |
| SLQKTWVGVAPAPLS | 566 | Q9HCM7 | |
| GSRIVLNPNKPVVEW | 441 | Q9BRR6 | |
| IQALSSAWVVLPPGK | 76 | Q5SQH8 | |
| LANLNPVTWVKTIGS | 621 | O71037 | |
| LANLNPVTWVKTIGS | 621 | Q902F8 | |
| WTLNQPLGISVLPLK | 506 | Q8N5R6 | |
| LPASQIIPTAKETWL | 391 | P15085 | |
| LTPGFTLQKWNDPTT | 396 | P51816 | |
| GPGNQKTWIPRVLST | 1176 | Q8TCU4 | |
| GSPQTQGIIWKRPTE | 66 | A6NHC0 | |
| PNGVIKSPLLWSFIV | 616 | Q96K78 | |
| IVPILWIKNGTTQPL | 611 | Q6Q4G3 | |
| LGWIPRAGVTKPQTN | 526 | Q8N865 | |
| PKQTGPVIIETWVAE | 2001 | Q12830 | |
| EIPLTWIQPGTTVLN | 276 | Q6UB35 | |
| LPVNSQKITLEWASP | 381 | Q8WWH4 | |
| ESNPVIWTKIRVPGN | 1171 | P58397 | |
| VKSWTNLRLQTLPPV | 541 | O95803 | |
| QNPPVIKSSGRFLWI | 121 | Q8TDF5 | |
| LALGDPKPQVTWSKV | 3511 | P98160 | |
| QITVNLGPEDWKPQT | 186 | A8MUP6 | |
| TELVSEGPVPWVSKN | 476 | Q96SU4 | |
| LQWLTPEQTSGKEHP | 116 | P09960 | |
| PGKELWSPIQQVTAT | 211 | Q6NTE8 | |
| QPVKLPAVWSITTLN | 531 | P32926 | |
| QVDTTKAVITLQPPW | 16 | Q92637 | |
| STGTIPKEIPAWGQL | 316 | Q14626 | |
| EWVKDPLQLTSNPLG | 41 | O60309 | |
| EWVKDPLQLTSNPLG | 41 | A6NM11 | |
| EWVKDPLQLTSNPLG | 41 | A6NMS7 | |
| GPGVLKVLWLTASQP | 246 | Q643R3 | |
| WKKAVPSESPGVLQL | 51 | Q9H2G9 | |
| QLIINPTGWKPSISQ | 141 | P50391 | |
| PEPQLSWSKDGVVLQ | 1191 | Q8NDA2 | |
| LASQGNPPLKEWQSL | 701 | Q08426 | |
| PPTALSTDQGLVQWL | 1211 | O95382 | |
| KPAAQISWIPEGSIL | 166 | Q6Q8B3 | |
| RVWPVNTPGKSLESQ | 556 | Q2TBE0 | |
| PLLIDPQTQGKTWIK | 3466 | Q96JB1 | |
| PTGNSATPQILELKW | 1726 | Q5H8C1 | |
| LKSQPLVPRENITAW | 1131 | Q9ULK4 | |
| PSSVTWQGITNLKLI | 306 | P50748 | |
| QPLVWVKDPLQLTSN | 26 | Q96QE4 | |
| LSGLAIKVPPSVDQW | 241 | Q96RT7 | |
| WSPELLQSPTGLKIV | 351 | Q8IXW0 | |
| SIVTPPKDIWNVTGA | 161 | Q16270 | |
| LANLNPVTWVKTIGS | 1381 | P63135 | |
| QEVDKSTWLLPPQAL | 556 | O95672 | |
| QDVTLKWATQLPHIP | 316 | Q3SYG4 | |
| KQLSGVTVKLSWQPP | 906 | Q9UMZ3 | |
| VKTIGSKWQPPISSL | 301 | Q9UGF6 | |
| GSKPSQVLQPLWAAS | 436 | P08648 | |
| LAWEILPQATPVSKQ | 341 | Q8WWV6 | |
| LANLNPVTWVKTIGS | 621 | P61570 | |
| LANLNPVTWVKTIGS | 621 | Q69384 | |
| IVQLLGTPSENIWPG | 251 | Q15131 | |
| SSGLKQIPIKWTAPE | 716 | P16591 | |
| GILETPVNPWKTNNV | 1751 | O75417 | |
| LENPVPQWDLSILGS | 11 | J3KSC0 | |
| EWNLQPLPKVISTLE | 576 | P09172 | |
| PSPKQSTIWVVVQVL | 1231 | Q8TDW7 | |
| KEQEWTPITGPLLAL | 421 | Q6NUI2 | |
| KFTPPVVNVTWLRNG | 136 | P01903 | |
| PLKISWLEGQPQDAV | 241 | Q9NVM6 | |
| EGQWVTLPAPLDTIN | 801 | P10253 | |
| QEPGVTLASLKPWTQ | 556 | P14616 | |
| QVDTTKAVITLQPPW | 16 | P12314 | |
| LPPVSGSIIWAKQID | 641 | Q14204 | |
| SPSQVAVVPWGLRKV | 841 | Q9UEF7 | |
| WLKPQKIIPTVNVGT | 1006 | Q6PJP8 | |
| TGWLLTITETKQPQP | 1596 | Q5TBA9 | |
| VWPQIVQGLEEKLPS | 316 | Q14746 | |
| SEWLGNKLTPLQSVP | 441 | Q13183 | |
| AQPWLSTSTEGLKIP | 376 | Q7Z5L9 | |
| PPGNVVWNATDTKVL | 906 | Q9P232 | |
| IPGGTPSLKILWLNQ | 671 | Q96EK7 | |
| KSWNQGTPPLELLAE | 426 | O94851 | |
| QGTSWLEQLPPKVEG | 311 | Q68BL7 | |
| IPQLLVNLWGPEKTI | 81 | O76001 | |
| QGSKELTTPLVNQWP | 331 | Q59EK9 | |
| LQIDWVSPRKPNGII | 3126 | O75445 | |
| VLLNWTKPESPNGII | 3981 | O75445 | |
| NVWAPKPVQALLSSS | 371 | Q9UGK8 | |
| PRVLSNTGWGQTPVK | 441 | Q9HCJ0 | |
| LKPFPLWTGKQVVST | 676 | O95602 | |
| LGPWNQCQPVISKSL | 126 | Q9UPZ6 | |
| WPPGRLQTVTKGVES | 11 | Q8TCC3 | |
| NVVIWLPSRPVKQGE | 291 | Q8N3T6 | |
| SQGPVSVWKAIPALQ | 256 | Q9Y345 | |
| WITPSGQKLLPNTLT | 456 | Q9H3W5 | |
| IVGLTQWSKSTLQLP | 56 | Q9UJD0 | |
| QWSKSTLQLPQPEGA | 61 | Q9UJD0 | |
| NTPLVPSGVKSWAQA | 131 | P48634 | |
| PTILKPVTLWTGKQI | 586 | O14802 | |
| SWPTLNTLIKIIGNS | 821 | Q14524 | |
| TQWKGTVLDQVPINP | 66 | Q99865 | |
| TLEGQLWPETLKNSP | 31 | Q6P1J6 | |
| IVAVELLPKSQWVAP | 291 | Q9Y2L1 | |
| LLPKSQWVAPSSVVL | 296 | Q9Y2L1 | |
| LVWVDGEPPQQITSL | 631 | Q9Y2K9 | |
| IPWLSEASLVNKPLV | 16 | O95561 | |
| LASVISRKPSQGQWP | 11 | Q99757 | |
| QSVEPLTGWKSPASL | 141 | Q9H1E5 | |
| TPNWLSVLVDNLPGT | 216 | O00300 | |
| WLPKPNVISLLEQEA | 56 | P52742 | |
| TVWLPGKSPNEANLI | 1566 | O15027 | |
| SIAWPETLKQLIQPI | 701 | Q7RTY8 | |
| NPKPIVTWLKEGTLL | 166 | Q9UPX0 | |
| QWKGTVLDQVPVNPS | 71 | Q9Y657 | |
| TQWKGTVLDQVPVNP | 66 | Q5JUX0 | |
| TQWKGTVLDQVPINP | 66 | Q9BPZ2 | |
| KVQGRPSPQAIWSIT | 721 | Q7Z6L1 | |
| TPVLVSQLEQGELPW | 56 | Q6ZNG0 | |
| SVQPWAESGKVLVVP | 21 | P35504 | |
| LSTVPLDWVTVPKLQ | 476 | Q7Z410 | |
| QLIINPTGWKPSISQ | 141 | P0DQD5 | |
| IWDISQPGSKSPISQ | 511 | Q04726 | |
| PRLITTWEKVPVGTN | 201 | Q96HH6 | |
| NVLPGLSTWQSVIKL | 96 | Q6UWM9 | |
| WTDPIERPKQNIITG | 1301 | Q9BXT5 | |
| QVPKLVQWLISIGAS | 181 | O15050 | |
| VTEKQQGSWPLVLTL | 346 | Q08ET2 | |
| SVQPWAESGKVLVVP | 21 | P22310 | |
| TPKWVPVLGELQKTL | 16 | Q8N5Q1 | |
| DTKPGNVTWNSLAIP | 211 | Q8IZF0 | |
| TPSLVWVLPNGTDLQ | 2571 | Q9NR99 | |
| PKGWISENIPIVITT | 236 | Q9NPC6 | |
| ISENIPGKWTKNGLP | 456 | Q00872 | |
| DPAPTVIWQKAITQG | 676 | Q14896 |